Latest Advances

  • Condition: Advanced Pancreatic Neuroendocrine Neoplasms
  • Journal: Current oncology reports
  • Treatment Used: Systemic Treatment
  • Published —
This review of the literature evaluated systemic treatments for patients with pancreatic neuroendocrine neoplasms (abnormal growths; panNENs).
  • Condition: Large Paraganglioma
  • Journal: Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti
  • Treatment Used: Multiple Organ Resection
  • Published —
This case report describes a patient diagnosed with a rare case of a large paraganglioma (neuroendocrine tumor) of the left retroperitoneum treated with radical surgery.
  • Journal: Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • Published —
Clinical analysis of 15 cases of laryngeal schwannoma
  • Journal: Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • Published —
Analysis of efficacy of coblation assisted endoscope system for the treatment of parapharyngeal space tumors with transoral approach
  • Journal: Radiation oncology (London, England)
  • Published —
Vestibular dose correlates with dizziness after radiosurgery for the treatment of vestibular schwannoma.
  • Condition: Gastroenteropancreatic Neuroendocrine Tumors
  • Journal: JAMA network open
  • Treatment Used: Peptide Receptor Radionuclide Therapy
  • Number of Patients: 78
  • Published —
This study examined the safety and effects of peptide receptor radionuclide therapy (PRRT) for patients with gastroenteropancreatic neuroendocrine tumors (NETs).
  • Condition: Neuroendocrine Tumors with Liver Metastases
  • Journal: Croatian medical journal
  • Treatment Used: Liver Transplantation
  • Number of Patients: 12
  • Published —
This study evaluated the use of liver transplantation (LT) in unresectable neuroendocrine tumors (NET) with liver metastases.
  • Condition: Advanced Solid Tumors
  • Journal: Scientific reports
  • Treatment Used: Sorafenib plus S-1
  • Number of Patients: 0
  • Published —
This study determined the dose-limiting toxicity (DLT) and maximal tolerated dose (MTD) of S-1 when combined with sorafenib for the treatment of patients with refractory solid tumors.
  • Condition: Stage IV Large Cell Neuroendocrine Carcinoma of the Lung.
  • Journal: Asian Pacific journal of cancer prevention : APJCP
  • Treatment Used: Immunotherapy
  • Number of Patients: 37
  • Published —
This study defined the role of immunotherapy in the treatment of patients with large cell neuroendocrine carcinoma (LCNEC).
  • Condition: Neuroendocrine (Carcinoid) Tumors and Carcinoid Heart Disease
  • Journal: JACC. Clinical electrophysiology
  • Treatment Used: Catheter Ablation
  • Number of Patients: 17
  • Published —
The study researched the outcomes of catheter ablation for patients with neuroendocrine (carcinoid) tumors and carcinoid heart disease.
Showing 1-12 of 581